About Leica Biosystems

Leica Biosystems develops workflow and automation solutions for anatomic pathology and cancer diagnostics. With over 150 years of experience, the company provides a comprehensive portfolio from biopsy to diagnosis, including histology equipment, immunohistochemistry instruments, digital pathology scanners, and consumables. Over 3,000 experts support laboratories and partners globally. The company tackles pathology challenges through integrated solutions that streamline slide preparation, optimise staining, and advance digital pathology for AI. As part of Danaher Corporation, Leica Biosystems combines scientific expertise with continuous innovation to help clinicians deliver timely, accurate diagnostic answers to patients facing cancer.